R&G PharmaStudies Co., Ltd. (SHE:301333)
China · Delayed Price · Currency is CNY 66.28
+0.49 (0.74%)
At close: Mar 5, 2026
26.56% (1Y)
| Market Cap | 6.30B +32.7% |
| Revenue (ttm) | 789.45M +4.1% |
| Net Income | 151.37M +25.0% |
| EPS | 1.59 +26.1% |
| Shares Out | 95.14M |
| PE Ratio | 41.59 |
| Forward PE | 42.29 |
| Dividend | 0.16 (0.24%) |
| Ex-Dividend Date | Jul 8, 2025 |
| Volume | 1,067,014 |
| Average Volume | 2,151,595 |
| Open | 66.90 |
| Previous Close | 65.79 |
| Day's Range | 65.75 - 67.27 |
| 52-Week Range | 40.99 - 91.78 |
| Beta | 0.71 |
| RSI | 38.86 |
| Earnings Date | Mar 28, 2026 |